Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Phillips

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Experimental Cell Research|August 16, 2005
Matrix metalloproteinase activity synergizes with alpha2beta1 integrins to enhance collagen remodelingJonathan A Phillips, Lawrence J Bonassar
Biochemical and Biophysical Research Communications|December 19, 2003
Fibroblasts regulate contractile force independent of MMP activity in 3D-collagenJonathan A Phillips, Charles A Vacanti, Lawrence J Bonassar
Methods in Molecular Biology (Clifton, N.J.)|June 27, 2006
Collagen gel contraction assayPeter Ngo, Punitha Ramalingam, Jonathan A Phillips, et al.
Clinical Pharmacology and Therapeutics|July 10, 2023
Clinical Pharmacology and Translational Considerations in the Development of CRISPR-Based TherapiesAhmed M Abdelhady, Jonathan A Phillips, Yuanxin Xu, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|February 1, 2013
Assessment of inhibin B as a biomarker of testicular injury following administration of carbendazim, cetrorelix, or 1,2-dibromo-3-chloropropane in Wistar han ratsJeffrey S Moffit, Leah S Her, Anthony M Mineo, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 6, 2016
Net Reclassification Index and Integrated Discrimination Index Are Not Appropriate for Testing Whether a Biomarker Improves Predictive PerformancePeter M Burch, Warren E Glaab, Daniel J Holder, et al.
Chemical Research in Toxicology|September 9, 2017
A Multiplatform Approach for the Discovery of Novel Drug-Induced Kidney Injury BiomarkersLiuxi Chen, James Smith, Jaromir Mikl, et al.
Journal of Applied Toxicology : JAT|April 8, 2022
Mode of action and human relevance assessment of male CD-1 mouse renal adenocarcinoma associated with lifetime exposure to empagliflozinJonathan A Phillips, Mitchell E Taub, Matthew S Bogdanffy, et al.
Lab on a Chip|January 29, 2020
A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapiesJonathan A Phillips, Taraka Sai Pavan Grandhi, Myrtle Davis, et al.
Toxicologic Pathology|June 28, 2018
Pathogenesis of Renal Injury and Gene Expression Changes in the Male CD-1 Mouse Associated with Exposure to EmpagliflozinBrian Knight, Jing Yuan, Sally Koegler, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Experimental Cell Research|August 16, 2005
Matrix metalloproteinase activity synergizes with alpha2beta1 integrins to enhance collagen remodelingJonathan A Phillips, Lawrence J Bonassar
Biochemical and Biophysical Research Communications|December 19, 2003
Fibroblasts regulate contractile force independent of MMP activity in 3D-collagenJonathan A Phillips, Charles A Vacanti, Lawrence J Bonassar
Methods in Molecular Biology (Clifton, N.J.)|June 27, 2006
Collagen gel contraction assayPeter Ngo, Punitha Ramalingam, Jonathan A Phillips, et al.
Clinical Pharmacology and Therapeutics|July 10, 2023
Clinical Pharmacology and Translational Considerations in the Development of CRISPR-Based TherapiesAhmed M Abdelhady, Jonathan A Phillips, Yuanxin Xu, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|February 1, 2013
Assessment of inhibin B as a biomarker of testicular injury following administration of carbendazim, cetrorelix, or 1,2-dibromo-3-chloropropane in Wistar han ratsJeffrey S Moffit, Leah S Her, Anthony M Mineo, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 6, 2016
Net Reclassification Index and Integrated Discrimination Index Are Not Appropriate for Testing Whether a Biomarker Improves Predictive PerformancePeter M Burch, Warren E Glaab, Daniel J Holder, et al.
Chemical Research in Toxicology|September 9, 2017
A Multiplatform Approach for the Discovery of Novel Drug-Induced Kidney Injury BiomarkersLiuxi Chen, James Smith, Jaromir Mikl, et al.
Journal of Applied Toxicology : JAT|April 8, 2022
Mode of action and human relevance assessment of male CD-1 mouse renal adenocarcinoma associated with lifetime exposure to empagliflozinJonathan A Phillips, Mitchell E Taub, Matthew S Bogdanffy, et al.
Lab on a Chip|January 29, 2020
A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapiesJonathan A Phillips, Taraka Sai Pavan Grandhi, Myrtle Davis, et al.
Toxicologic Pathology|June 28, 2018
Pathogenesis of Renal Injury and Gene Expression Changes in the Male CD-1 Mouse Associated with Exposure to EmpagliflozinBrian Knight, Jing Yuan, Sally Koegler, et al.
Pageof 2